{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:32:12Z","timestamp":1791855132528,"version":"4.3.4"},"reference-count":121,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.bbalip.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,10,13]],"date-time":"2013-10-13T00:00:38Z","timestamp":1381622438000},"page":"323-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Lipid abnormalities and lipid-based repair strategies in atopic dermatitis"],"prefix":"10.1016","volume":"1841","author":[{"given":"Peter M.","family":"Elias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2013.10.001_bb0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archderm.139.11.1417","article-title":"The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease","volume":"139","author":"Sugarman","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2340\/0001555575429433","article-title":"Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin","volume":"75","author":"Seidenari","year":"1995","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdermsci.2006.06.003","article-title":"Skin barrier function, epidermal proliferation and differentiation in eczema","volume":"43","author":"Proksch","year":"2006","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/mjd.2002.124617","article-title":"Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity","volume":"47","author":"Chamlin","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02980.x","article-title":"The role of microorganisms in atopic dermatitis","volume":"144","author":"Baker","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0030","first-page":"119","article-title":"Epidermal pathogenesis of inflammatory dermatoses","volume":"10","author":"Elias","year":"1999","journal-title":"Am. J. Contact Dermat."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0035","first-page":"1079","article-title":"Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications","volume":"137","author":"Elias","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0536.1999.tb06125.x","article-title":"Hypothesis: from epidermal barrier dysfunction to atopic disorders","volume":"41","author":"Taieb","year":"1999","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000096915","article-title":"The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study","volume":"214","author":"Grimalt","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.0022-202X.2005.23668.x","article-title":"Stratum corneum defensive functions: an integrated view","volume":"125","author":"Elias","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00281-007-0060-9","article-title":"The skin barrier as an innate immune element","volume":"29","author":"Elias","year":"2007","journal-title":"Sem Immunopath"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-024924-4.50005-5","article-title":"Structural and lipid biochemical correlates of the epidermal permeability barrier","volume":"24","author":"Elias","year":"1991","journal-title":"Adv. Lipid Res."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0065","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1038\/jid.2012.177","article-title":"Lamellar bodies: the key to cutaneous barrier function","volume":"132","author":"Feingold","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0070","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.0022-202X.2004.22512.x","article-title":"Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE\/KLK5\/hK5 and SCCE\/KLK7\/hK7","volume":"122","author":"Caubet","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0022-202X.2004.23547.x","article-title":"A proteolytic cascade of kallikreins in the stratum corneum","volume":"124","author":"Brattsand","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0080","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1038\/jid.2012.173","article-title":"Cellular changes that accompany shedding of human corneocytes","volume":"132","author":"Lin","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.0022-202X.2004.23443.x","article-title":"Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies","volume":"124","author":"Braff","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0014-4800(02)00023-0","article-title":"In human epidermis, beta-defensin 2 is packaged in lamellar bodies","volume":"74","author":"Oren","year":"2003","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.jid.5701099","article-title":"Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers","volume":"128","author":"Aberg","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0100","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/sj.jid.5700365","article-title":"Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis","volume":"126","author":"Irvine","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0406-399","article-title":"Skin barrier function and allergic risk","volume":"38","author":"Hudson","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0167-4838(83)90336-9","article-title":"The characterization of human epidermal filaggrin. A histidine-rich, keratin filament-aggregating protein","volume":"744","author":"Lynley","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-2836(83)80126-0","article-title":"Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation","volume":"170","author":"Harding","year":"1983","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/1523-1747.ep12277306","article-title":"Profilaggrin, a high-molecular-weight precursor of filaggrin in human epidermis and cultured keratinocytes","volume":"85","author":"Fleckman","year":"1985","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/abbi.1996.0199","article-title":"Filaggrin linker segment peptide and cystatin alpha are parts of a complex of the cornified envelope of epidermis","volume":"329","author":"Takahashi","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0130","doi-asserted-by":"crossref","first-page":"17702","DOI":"10.1074\/jbc.270.30.17702","article-title":"The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope","volume":"270","author":"Steinert","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0304-4165(82)90314-2","article-title":"Histidine-rich protein of the keratohyalin granules. Source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the stratum corneum","volume":"719","author":"Scott","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0140","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/1523-1747.ep12398620","article-title":"Stratum corneum moisturization at the molecular level","volume":"103","author":"Rawlings","year":"1994","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0145","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases","volume":"365","author":"Irvine","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0150","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaci.2008.08.002","article-title":"Filaggrin in atopic dermatitis","volume":"122","author":"O'Regan","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0155","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/sj.jid.5700876","article-title":"Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis","volume":"127","author":"Sandilands","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0160","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.ajpath.2011.01.053","article-title":"Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function","volume":"178","author":"Gruber","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0165","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/bjd.12219","article-title":"Ichthyosis vulgaris: the filaggrin mutation disease","volume":"168","author":"Thyssen","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0170","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1034\/j.1600-0625.2002.110406.x","article-title":"Absence of the granular layer and keratohyalin define a morphologically distinct subset of individuals with ichthyosis vulgaris","volume":"11","author":"Fleckman","year":"2002","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0180","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0185","series-title":"Skin Barrier","first-page":"569","article-title":"The stratum corneum of the epidermis in atopic dermatitis","author":"Jensen","year":"2005"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-0536.2008.01320.x","article-title":"Lipids and skin barrier function\u2014a clinical perspective","volume":"58","author":"Jungersted","year":"2008","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/ACI.0b013e3282a64343","article-title":"The role of human beta defensins and cathelicidins in atopic dermatitis","volume":"7","author":"Howell","year":"2007","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0200","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1684\/ejd.2013.1955","article-title":"Association of the chromosome 11q13.5 variant with atopic dermatitis in Austrian patients","volume":"23","author":"Greisenegger","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0205","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jaci.2012.12.1566","article-title":"Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin","volume":"131","author":"Pellerin","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0210","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2011.04.014","article-title":"Ichthyosis prematurity syndrome: clinical evaluation of 17 families with a rare disorder of lipid metabolism","volume":"66","author":"Khnykin","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.08.027","article-title":"A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis","author":"Sasaki","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0220","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3349\/ymj.2010.51.6.808","article-title":"Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis","volume":"51","author":"Lee","year":"2010","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0225","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng728","article-title":"Gene polymorphism in Netherton and common atopic disease","volume":"29","author":"Walley","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0230","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/sj.jid.5700288","article-title":"Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome","volume":"126","author":"Hachem","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.0022-202X.2004.22708.x","article-title":"Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis","volume":"123","author":"Vasilopoulos","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0240","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2340\/00015555-0329","article-title":"Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort","volume":"87","author":"Hubiche","year":"2007","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0245","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2133.2005.06602.x","article-title":"Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern Germany","volume":"152","author":"Folster-Holst","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0250","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1523-1747.2003.12365.x","article-title":"pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity\/cohesion","volume":"121","author":"Hachem","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00015559850135788","article-title":"Ceramide and cholesterol composition of the skin of patients with atopic dermatitis","volume":"78","author":"Di Nardo","year":"1998","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0260","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/1523-1747.ep12470233","article-title":"Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?","volume":"96","author":"Imokawa","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12016-010-8231-1","article-title":"Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis","volume":"41","author":"Elias","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/edm.12.73","article-title":"Treating atopic dermatitis at the source: corrective barrier repair therapy based upon new pathogenic insights","volume":"8","author":"Elias","year":"2013","journal-title":"Exp. Rev. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0275","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1398-9995.2010.02326.x","article-title":"Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema","volume":"65","author":"Jungersted","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yadr.2007.07.011","article-title":"Ichthyosis update: towards a function-driven model of pathogenesis of the disorders of cornification and the role of corneocyte proteins in these disorders","volume":"23","author":"Schmuth","year":"2007","journal-title":"Adv. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0285","series-title":"IID 2008 Kyoto, Japan","article-title":"R501X, 2282del4 and R2447X founder mutations in the filaggrin gene in European ichthyosis vulgaris patients","author":"Gruber","year":"2008"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.jid.5701011","article-title":"Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges","volume":"128","author":"Man","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0295","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/sj.jid.5700351","article-title":"Serine protease signaling of epidermal permeability barrier homeostasis","volume":"126","author":"Hachem","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2009.04.006","article-title":"A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide","volume":"55","author":"Imokawa","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0305","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/0264-6021:3620619","article-title":"Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in ceramide hydrolysis on atopic skin by Pseudomonas ceramidase","volume":"362","author":"Kita","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/CDLI.6.1.101-104.1999","article-title":"Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis","volume":"6","author":"Ohnishi","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0315","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1523-1747.2002.01846.x","article-title":"Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus","volume":"119","author":"Arikawa","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2013.08.003","article-title":"Altered sphingoid base profiles predict compromised membrane structure and permeability in atopic dermatitis","author":"Loiseau","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0325","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/exd.12047","article-title":"The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis","volume":"22","author":"Hatano","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0330","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.jid.5701138","article-title":"IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo","volume":"128","author":"Kurahashi","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdermsci.2012.07.004","article-title":"Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis","volume":"68","author":"Sawada","year":"2012","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0340","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/jid.2008.80","article-title":"Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis","volume":"128","author":"Altrichter","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0345","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","article-title":"The skin: an indispensable barrier","volume":"17","author":"Proksch","year":"2008","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0350","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2008.01.022","article-title":"Basis for the barrier abnormality in atopic dermatitis: outside\u2013inside\u2013outside pathogenic mechanisms","volume":"121","author":"Elias","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0355","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1038\/jid.2010.161","article-title":"Changes in the ceramide profile of atopic dermatitis patients","volume":"130","author":"Ishikawa","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0360","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/jid.2011.333","article-title":"Decrease of ceramides with very long-chain fatty acids and downregulation of elongases in a murine atopic dermatitis model","volume":"132","author":"Park","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0365","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1194\/jlr.P030338","article-title":"Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients","volume":"53","author":"Janssens","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0370","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/jid.2011.175","article-title":"Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema","volume":"131","author":"Janssens","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0375","article-title":"Interferon-gamma decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis","author":"Tawada","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.bbalip.2013.10.001_bb0380","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40257-013-0033-9","article-title":"Barrier repair therapy in atopic dermatitis: an overview","volume":"14","author":"Hon","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0385","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/jid.2009.133","article-title":"Epidermal barrier dysfunction in atopic dermatitis","volume":"129","author":"Cork","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0390","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4049\/jimmunol.157.4.1699","article-title":"IL-1 beta activation in human epidermis","volume":"157","author":"Nylander-Lundqvist","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0395","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI115884","article-title":"Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice","volume":"90","author":"Wood","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0400","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/archderm.1996.03890360097017","article-title":"Signaling networks in barrier homeostasis. The mystery widens","volume":"132","author":"Elias","year":"1996","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0405","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/jid.2008.88","article-title":"\u201cOutside-to-inside\u201d (and now back to \u201coutside\u201d) pathogenic mechanisms in atopic dermatitis","volume":"128","author":"Elias","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0410","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pmed.0050131","article-title":"Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure","volume":"5","author":"Bisgaard","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0415","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/jid.2008.13","article-title":"Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery","volume":"128","author":"Jeong","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0420","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/sj.jid.5701190","article-title":"Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel","volume":"128","author":"Novak","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0425","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/586746","article-title":"Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis","volume":"46","author":"Schlievert","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0430","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1172\/JCI116711","article-title":"Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens","volume":"92","author":"Leung","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0435","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.0022-202X.2005.23916.x","article-title":"Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis","volume":"125","author":"Lomholt","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0440","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2133.2001.04352.x","article-title":"Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema","volume":"145","author":"Wehner","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0445","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0450","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archderm.1988.01670020027012","article-title":"In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids","volume":"124","author":"Miller","year":"1988","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0455","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/1523-1747.ep12497842","article-title":"Antimicrobial activity of sphingosines","volume":"98","author":"Bibel","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0460","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0465","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4049\/jimmunol.171.6.3262","article-title":"Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes","volume":"171","author":"Nomura","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0470","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2006.04.042","article-title":"New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene\u2013environment interactions","volume":"118","author":"Cork","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0475","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/jid.2013.128","article-title":"Childhood eczema and the importance of the physical environment","volume":"133","author":"Langan","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0480","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0012-1606(86)90230-7","article-title":"Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment","volume":"115","author":"Scott","year":"1986","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0485","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archderm.137.1.53","article-title":"Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders","volume":"137","author":"Garg","year":"2001","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0490","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.0022-202X.2005.23589.x","article-title":"Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity","volume":"124","author":"Choi","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0495","first-page":"S114","article-title":"Paradoxical benefits of psychological stress in mouse models of inflammatory dermatoses","author":"Santiago","year":"2013"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0500","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.2012.02845.x","article-title":"Atopic dermatitis: a candidate for disease-modifying strategy","volume":"67","author":"Bieber","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0505","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2165\/00128071-200304110-00005","article-title":"Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders","volume":"4","author":"Loden","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0510","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2133.2003.05595.x","article-title":"Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse","volume":"149","author":"Cork","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0515","first-page":"34","article-title":"Evaluating clinical use of a ceramide-dominant, physiologic lipid-based topical emulsion for atopic dermatitis","volume":"4","author":"Kircik","year":"2011","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0520","first-page":"1037","article-title":"Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis","volume":"8","author":"Bikowski","year":"2009","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0525","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jdermsci.2008.02.007","article-title":"On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramides","volume":"51","author":"Uchida","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0530","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1684\/ejd.2011.1447","article-title":"Beneficial effects of pseudoceramide-containing physiologic lipid mixture as a vehicle for topical steroids","volume":"21","author":"Lee","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0535","series-title":"IID 2008 Kyoto, Japan","article-title":"A topical lipid-based barrier repair formulation (EpiCeram cream) is high-effective monotherapy for moderate-to-severe pediatric atopic dermatitis","author":"Sugarman","year":"2008"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0540","first-page":"923134","article-title":"Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectives","volume":"2012","author":"Valdman-Grinshpoun","year":"2012","journal-title":"Dermatol. Res. Prac."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0545","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1358\/dot.2008.44.10.1276838","article-title":"Epiceram for the treatment of atopic dermatitis","volume":"44","author":"Madaan","year":"2008","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0550","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0163-7827(81)90041-2","article-title":"Effects of topical application of fatty acids","volume":"20","author":"Houtsmuller","year":"1981","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0555","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clindermatol.2010.03.020","article-title":"Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids","volume":"28","author":"McCusker","year":"2010","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0560","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.nut.2009.10.014","article-title":"Borage oil in the treatment of atopic dermatitis","volume":"26","author":"Foster","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0565","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/09546634.2010.499932","article-title":"Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis","volume":"22","author":"De Belilovsky","year":"2011","journal-title":"J. Dermatol. Treat"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0570","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1399-3038.2010.01096.x","article-title":"Allergic disease in infants up to 2years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation","volume":"22","author":"Furuhjelm","year":"2011","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0575","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12016-009-8186-2","article-title":"Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review","volume":"41","author":"Kremmyda","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0580","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/0378-6323.42645","article-title":"Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial","volume":"74","author":"Senapati","year":"2008","journal-title":"Indian J. Dermatol. Venereol. Leprology"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0585","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1600-0625.2012.01501.x","article-title":"Dietary sphingolipids improve skin barrier functions via the upregulation of ceramide synthases in the epidermis","volume":"21","author":"Duan","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0590","first-page":"327","article-title":"Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study","volume":"11","author":"Amestejani","year":"2012","journal-title":"J. Drugs. Dermatol."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0595","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3346\/jkms.2010.25.5.766","article-title":"Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis","volume":"25","author":"Park","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.bbalip.2013.10.001_bb0600","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2013.10.001_bb0605","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/sj.jid.5701208","article-title":"Filaggrin expression in oral, nasal, and esophageal mucosa","volume":"128","author":"De Benedetto","year":"2008","journal-title":"J. Invest. Dermatol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198113002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198113002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T09:02:34Z","timestamp":1688547754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198113002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1388198113002163"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2013.10.001","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid abnormalities and lipid-based repair strategies in atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2013.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}